005500.KS · 삼진제약
South Korea · RS rating 82 · As of 2026-10-14
| Price | 19,760.00 KRW |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 79 / 66 / 66 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 32 / 52 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +338.2% |
| Sales growth Q/Q | +17.0% |
| Distance from 52-week high | +20.0% |
| Market cap (USD) | $189.5M |